Evosep, the Odense, Denmark-based innovator in liquid chromatography, has announced a pivotal expansion of its offerings with the launch of…
Read More
Evosep Unveils Evosep Proteomics: A Standardized Ecosystem for Scaling LC-MS-Based Proteomics in Research and Drug Development
Odense, Denmark – Evosep, a leading innovator in liquid chromatography solutions, has announced the launch of Evosep Proteomics, a comprehensive…
Read More
Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access
In a landmark decision poised to reshape the landscape of diabetes and obesity management, Health Canada has granted authorization to…
Read More
Popular Anti-Aging Drug Combination Linked to Significant Myelin Damage and Brain Deterioration in UConn Study
A pharmaceutical combination that has become a cornerstone of modern anti-aging and longevity research may pose a severe risk to…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…
Read More
NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus
The National Institutes of Health (NIH) has released a groundbreaking study detailing the complex intracellular signaling processes triggered by GLP-1…
Read More
The $1.8 Billion Telehealth Conundrum: Medvi’s Rise Amidst Regulatory Gaps, AI Deception, and the Compounded Drug Market
A recent profile by The New York Times celebrated Medvi, a burgeoning telehealth enterprise, as a testament to the transformative…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace Medicine
Deep within the skeletal framework of the human body lies a complex, high-performance factory: the bone marrow. This sponge-like tissue…
Read More
